Abstract:BackgroundN6-methyladenosine (m6A) methylation, a well-known modification with new epigenetic functions, has been reported to participate in the tumorigenesis of hepatocellular carcinoma (HCC), providing novel insights into the molecular pathogenesis of this disease. However, as the key component of m6A methylation, Wilms tumor 1-associated protein (WTAP) has not been well studied in HCC. Here we investigated the biological role and underlying mechanism of WTAP in liver cancer.MethodsWe determined the expression of WTAP and its correlation with clinicopathological features using tissue microarrays and the Cancer Genome Atlas (TCGA) dataset. And we clarified the effects of WTAP on HCC cells using cell proliferation assay, colony formation, Edu assay and subcutaneous xenograft experiments. We then applied RNA sequencing combined with gene expression omnibus (GEO) data to screen candidate targets of WTAP. Finally, we investigated the regulatory mechanism of WTAP in HCC by m6A dot blot assay, methylated RNA immunoprecipitation (MeRIP) assay, dual luciferase reporter assay, RNA immunoprecipitation (RIP) assay and Chromatin immunoprecipitation (ChIP) assay.ResultsWe demonstrated that WTAP was highly expressed in HCC which indicated the poor prognosis, and that WTAP expression served as an independent predictor of HCC survival. Functionally, WTAP promoted the proliferation capability and tumor growth of HCC cells in vitro and in vivo. Furthermore, ETS proto-oncogene 1 (ETS1) was identified as the downstream effector of WTAP. The m6A modification regulated by WTAP led to post-transcriptional suppression of ETS1, with the implication of Hu-Antigen R (HuR) as an RNA stabilizer. Then ETS1 was found to inhibit the progression of HCC and could rescue the phenotype induced by WTAP deficiency. Moreover, WTAP modulated the G2/M phase of HCC cells through a p21/p27-dependent pattern mediated by ETS1.ConclusionWe have identified that WTAP is significantly up-regulated in HCC and promotes liver cancer development. WTAP-guided m6A modification contributes to the progression of HCC via the HuR-ETS1-p21/p27 axis. Our study is the first to report that WTAP-mediated m6A methylation has a crucial role in HCC oncogenesis, and highlights WTAP as a potential therapeutic target of HCC treatment.

WTAP Mediated N6-methyladenosine RNA Modification of ELF3 Drives Cellular Senescence by Upregulating IRF8

METTL14 Regulates Intestine Cellular Senescence Through M6a Modification of Lamin B Receptor

METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA

WTAP-mediated m<SUP>6</SUP>A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis

WTAP-mediated m 6 A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis

Identification of Four Biomarkers of Human Skin Aging by Comprehensive Single Cell Transcriptome, Transcriptome, and Proteomics

Dynamic Alteration Profile and New Role of RNA m6A Methylation in Replicative and H2O2-Induced Premature Senescence of Human Embryonic Lung Fibroblasts

The m6A writer KIAA1429 regulates photoaging progression via MFAP4-dependent collagen synthesis

Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis

m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation

Ythdf1 Promotes Renal Aging by Enhancing Tlr4 Mrna Stability Via Mettl14-Mediated M6a Methylation

METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging

WTAP increases BMP2 expression to promote osteoblast differentiation and inhibit osteoblast senescence via m6A methylation of Sp1

The N6‐methyladenosine landscape of ovarian development and aging highlights the regulation by RNA stability and chromatin state

Advanced glycation end products alter the m6A-modified RNA profiles in human dermal fibroblasts

Emerging Role of Dermal White Adipose Tissue in Modulating Hair Follicle Development During Aging

WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1

Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase

m 6A methylation in cellular senescence of age-associated diseases

FTO-mediated regulation of m6A methylation is closely related to apoptosis induced by repeated UV irradiation

Exosomal miR-767 from senescent endothelial-derived accelerating skin fibroblasts aging via inhibiting TAB1